Paul Nguewa

20PUBLICATIONS
31CO-AUTHORS
Biologically active moleculesPharmaceutical delivery technologiesMolecular medicineMedical molecular engineering of nucleic acids and proteinsOther European languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 28, 2026
Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by <i>Leishmania major</i>.

Rima El-Dirany, Paolo Ginatta, Celia Fernández-Rubio

|Feb 27, 2026
Tetronic<sup>®</sup> 1307-Based Polymeric Micelles and Thermoresponsive Gels for the Co-Delivery of Pentamidine and Miltefosine.

Javier Carriles, Carlos Aydillo, Gregory N Smith

|Feb 13, 2026
Pluronic<sup>®</sup> F127 Polymeric Micelles as Nanocarriers for Pentamidine: Improving Safety and Biological Efficacy Against <i>Leishmania major</i>.

Kristell Panta Quezada, Gustavo González-Gaitano, Paul Nguewa

|Jan 28, 2026
Pentamidine-Functionalized Polycaprolactone Nanofibers Produced by Solution Blow Spinning for Controlled Release in Cutaneous Leishmaniasis Treatment.

Nerea Guembe-Michel, Paul Nguewa, Gustavo González-Gaitano

|Sep 26, 2025
Agreement Document for the Study of Leishmaniasis from a One Health Approach in Spain.

Joaquina Martín-Sánchez, Jose M Requena, Montserrat Gállego

|Aug 28, 2025
The Role of BRCT Domain from LmjPES in <i>Leishmania major</i> Pathogenesis.

Esther Larrea, José Peña-Guerrero, Celia Fernández-Rubio

Pageof 4

Frequent Collaborators

9 joint publications

José Peña-Guerrero

9 joint publications

Celia Fernández-Rubio

6 joint publications

Esther Larrea

6 joint publications

Gustavo Gonzalez-Gaitano